Home » Spectranetics Earns CE Mark for AngioSculptX Drug-coated Catheter
Spectranetics Earns CE Mark for AngioSculptX Drug-coated Catheter
Spectranetics has attained CE Mark approval in the EU for its AngioSculptX drug-coated balloon catheter designed to treat coronary artery stenosis.
The device also was granted indications for the treatment of hemodynamically significant coronary artery stenosis, including in-stent restinosis, the company said.
It is meant to be used in percutaneous transluminal coronary angioplasty procedures. — Cynthia Jessup
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May